Open Now
Contact Information
810 West Reid Avenue Suite 2, North Platte, Nebraska 69101, United States
Detailed Information
Psychiatric Hope
-
Services:
- Acamprosate (Campral®)
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Lofexidine
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Nicotine replacement
- Buprenorphine with naloxone
- Clonidine
- Disulfiram
- Private for-profit organization
- Alcohol Detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Cocaine Detoxification
- Benzodiazepines Detoxification
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Federal, or any government funding for substance use treatment programs
- Private health insurance
- Cash or self-payment
- Medicaid
- IHS/Tribal/Urban (ITU) funds
- Medicare
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
- SAMHSA funding/block grants
- Treatment for other addiction disorder
- Children/Adolescents
- In-network prescribing entity
- Drug or alcohol urine screening
- Smoking not permitted
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Mentoring/peer support
- Housing services
- Assistance with obtaining social services
- Residential/24-hour residential
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Long-term residential
- Residential detoxification
- Regular outpatient treatment
- Intensive outpatient treatment
- Short-term residential
- Outpatient
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Individual counseling
- Health education services other than HIV/AIDS or hepatitis
- Aftercare/continuing care
- Naloxone and overdose education
- Screening for substance use
- Comprehensive substance use assessment
- Professional interventionist/educational consultant
- Interim services for clients
- Comprehensive mental health assessment
- Screening for tobacco use
- Outreach to persons in the community
- Screening for mental disorders
- Complete medical history/physical exam
- Mental health services
- Suicide prevention services
- Telemedicine/telehealth therapy
- Brief intervention
- Substance use disorder counseling
- Relapse prevention
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Vaping not permitted
- Male
- Female
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- Lofexidine or Clonidine detoxification
- Buprenorphine maintenance
- Buprenorphine detoxification
- Federally Qualified Health Center
Pharmacotherapies
Facility Operation (e.g., Private, Public)
Detoxification (medical withdrawal) Services
Type of Care
Payment/Insurance/Funding Accepted
Other Services
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Testing
Facility Smoking Policy
Type of Alcohol Use Disorder Treatment
Recovery Support Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Education and Counseling Services
Transitional Services
Assessment/Pre-treatment
Ancillary Services
Treatment Approaches
Opioid Medications used in Treatment
Facility Vaping Policy
Gender Accepted
Type of Opioid Treatment
License/Certification/Accreditation
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
